We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+15.25%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$133M
AUM Growth
+$5.69M
Cap. Flow
+$3.69M
Cap. Flow %
2.77%
Top 10 Hldgs %
72.54%
Holding
56
New
1
Increased
8
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$1.79M
2
STOK icon
Stoke Therapeutics
STOK
+$745K
3
IMGN
Immunogen Inc
IMGN
+$472K
4
AXGN icon
Axogen
AXGN
+$373K
5
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$365K

Top Sells

Rank Stock Value
1
HROW icon
Harrow
HROW
+$660K
2
IFRX icon
InflaRx
IFRX
+$89.5K
3
NKTR icon
Nektar Therapeutics
NKTR
+$64K
4
ELTX icon
Elicio Therapeutics
ELTX
+$32K
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$22K

Sector Composition

Rank Sector Weight
1 Healthcare 96.02%
2 Energy 3.95%
3 Consumer Staples 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOSS icon
51
Gossamer Bio
GOSS
$72M
$119K 0.09%
99,088
– –
GTHX
52
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$99.6K 0.07%
40,000
– –
YTEN
53
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$41.6K 0.03%
781
– –
NKTR icon
54
Nektar Therapeutics
NKTR
$2.22B
$16.1K 0.01%
1,867
-6,000
-76% -$64K
ELTX icon
55
Elicio Therapeutics
ELTX
$79.8M
– –
-5,439
Closed -$32K
AWH
56
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
– –
-4,005
Closed -$22K
1 2
3

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Birchview Capital held 56 positions worth $133M, up 4.5% from $128M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Birchview Capital's Q2 2023 filing shows 1 new, 8 increased, 3 reduced and 2 closed positions. Its largest new stake was Axogen: 40,000 shares worth $365K. The largest sale was Harrow, an estimated $660K.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier, followed by Energy and Consumer Staples.

  • Birchview Capital's largest Q2 2023 buy was Axogen: 40,000 shares worth $365K.
  • Birchview Capital added most to Prothena Corp in Q2 2023, an estimated $1.79M increase.
  • Birchview Capital's biggest Q2 2023 reduction was Harrow, cutting an estimated $660K.
  • Birchview Capital fully exited Elicio Therapeutics in Q2 2023, selling an estimated $32K.
  • Birchview Capital's ten largest holdings make up 73% of its $133M portfolio in Q2 2023.
  • Birchview Capital opened 1 new position and closed 2 in Q2 2023.
  • Birchview Capital's portfolio value rose 4.5% quarter-over-quarter to $133M.

Based on Birchview Capital's 13F filing for Q2 2023, filed 8 Aug 2023.